Ke-yu Deng
Nanchang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Human Urine Stem Cells Alleviate Pulmonary Fibrosis via Inhibiting Macrophage-Myofibroblast Transition.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 17, 2026
Myeloid Cdc42 deficiency-mediated macrophage pyroptosis exacerbates diabetic cardiomyopathy in type 1 diabetes mellitus.
Journal: Cardiovascular diabetology
Published: February 09, 2026
MIF tautomerase inhibitor 4-IPP alleviates HFD-induced obesity by restoring CD137-mediated browning of white adipocytes in mice.
Journal: Acta pharmacologica Sinica
Published: July 25, 2025
Serine inhibits granulosa cell ferroptosis to maintain ovarian function.
Journal: Nature communications
Published: July 16, 2025
FK506 binding protein 12.6-mediated inhibition of sperm-specific calcineurin is essential for FK506-induced male infertility by disturbing the homeostasis of calcium and mitochondria.
Journal: Molecular biomedicine
Published: July 14, 2025
Human urine-derived stem cells alleviate psoriasis by suppressing JAK2/STAT3 pathway-mediated macrophage polarization.
Journal: Stem cell research & therapy
Published: July 14, 2025
Hexokinase 2-mediated histone H3K18la promotes PAI-1-dependent thrombosis in acute myeloid leukemia via tumor-endothelial crosstalk.
Journal: Nature communications
Published: March 31, 2025
Long-term hypoxic atmosphere enhances the stemness, immunoregulatory functions, and therapeutic application of human umbilical cord mesenchymal stem cells.
Journal: Bone & joint research
Published: December 11, 2024
Cardiomyocyte specific CD38 deletion protects heart from acute myocardial infarction by activating Sirt3 signaling pathway.
Journal: Scientific reports
Published: November 24, 2024
SNX16 aggravates AngII-induced cardiac hypertrophy in mice via EGFR transactivation.
Journal: Communications biology
Published: November 02, 2024
Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury.
Journal: Signal transduction and targeted therapy
Published: October 19, 2024
CD38 deficiency prevents diabetic nephropathy by inhibiting lipid accumulation and oxidative stress through activation of the SIRT3 pathway.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire
Published: August 08, 2024
Last Updated: 09/26/2026